[Federal Register: August 27, 1997 (Volume 62, Number 166)]
[Notices]
[Page 45394]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27au97-37]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Order No. 916]
Grant of Authority for Subzone Status; Minnesota Mining &
Manufacturing Company; (Pharmaceutical Products) Los Angeles,
California
Pursuant to its authority under the Foreign-Trade Zones Act of June
18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade Zones Board
(the Board) adopts the following Order:
Whereas, by an Act of Congress approved June 18, 1934, an Act ``To
provide for the establishment * * * of foreign-trade zones in ports of
entry of the United States, to expedite and encourage foreign commerce,
and for other purposes,'' as amended (19 U.S.C. 81a-81u) (the Act), the
Foreign-Trade Zones Board (the Board) is authorized to grant to
qualified corporations the privilege of establishing foreign-trade
zones in or adjacent to U.S. Customs ports of entry;
Whereas, the Board's regulations (15 CFR part 400) provide for the
establishment of special-purpose subzones when existing zone facilities
cannot serve the specific use involved;
Whereas, an application from the Board of Harbor Commissioners of
the City of Los Angeles, California, grantee of Foreign-Trade Zone 202,
for authority to establish special-purpose subzone status at the
pharmaceutical manufacturing plant of the Minnesota Mining &
Manufacturing Company, in Los Angeles, California, was filed by the
Board on May 15, 1996, and notice inviting public comment was given in
the Federal Register (FTZ Docket 41-96, 61 FR 26157, 5-24-96); and,
Whereas, the Board adopts the findings and recommendations of the
examiner's report, and finds that the requirements of the FTZ Act and
Board's regulations are satisfied, and that approval of the application
is in the public interest;
Now, Therefore, the Board hereby grants authority for subzone
status at the pharmaceutical manufacturing plant of the Minnesota
Mining & Manufacturing Company, located in Los Angeles, California
(Subzone 202A), at the location described in the application, and
subject to the FTZ Act and the Board's regulations, including
Sec. 400.28.
Signed at Washington, DC, this 20th day of August 1997.
Robert S. LaRussa,
Assistant Secretary of Commerce for Enforcement and Compliance, Alternate
Chairman, Foreign-Trade Zones Board.
[FR Doc. 97-22818 Filed 8-26-97; 8:45 am]
BILLING CODE 3510-DS-P